Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 12 member and observer countries with diverse trial support services
and contribute to 'infrastructure development' projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial

Events

Date:

EOSC is launching a series of webinars to share the work and notable results of the project. Join in for one or more:

  • EOSC business model recommendations, 15 Sep 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome) 
    Session details | Register now
  • Integrating services into EOSC through EOSC-hub, 29 Sep 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
  • EOSC-hub Technical Architecture, 13 Oct 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
  • EOSC Portal orders - The user and provider perspectives, 27 Oct 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
  • Using compute services in EOSC: Experiences and advices from EOSC-hub, 10 Nov 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
Date:

Save the date for the online workshop by EuroStemCell. More information coming shortly

Date:

REGISTRATION IS NOW OPEN

EULAC-Permed will be hosting their second technical workshop. This workshop aims to address the ethical, legal and social aspects in personalised medicine. 

Objective of the workshop: To exchange insights on key ethical, legal and social issues in personalised medicine (PM) research and implementation in Europe and in Latin America and the Caribbean (LAC) and identify recommendations for future bi-regional collaborations in the field of PM.

Target audience: The research and clinical care community that directly works with PM. This can be investigators, PhD students, project managers, clinicians and paramedical personnel. It can also include policy makers, representatives of ethics committees, funding bodies and other regulatory bodies who regulate PM research or policies on PM in the health systems.

For more information visit the website